Main loop post counter: 1

Message From The President

  • July 3, 2024

Message From The President

Elenaphoto2022cropped LT e1655825451678
Elena Sturman, President & CEO

Dear Readers,

Here at the Foundation, we ended our busy spring season on June 8 when TGF, in conjunction with Evolve Medical Education, held its second medical symposium offering accredited continuing education to ophthalmologists and optometrists across the country.

Some 80 eye-care professionals joined us in person at the New York City Bar Association for a day of presentations by experts from such institutions as Harvard, Columbia, UC San Diego, SUNY, Mount Sinai, and the University of Miami. Close to 300 others attended the symposium on Zoom from throughout the U.S., as well as from Brazil, Iran, Israel, Lebanon, Mexico, Nigeria, and Peru.

Titled “Glaucoma – What I Do,” the presentations by distinguished glaucoma professionals covered such topics as diagnosis, therapies, the use of AI, and other hot topics. The goal was to bring optometrists together with ophthalmologists to explore the best possible treatment for glaucoma and inspire better patient care.

I thank our partners Alcon, Bausch & Lomb, Théa Pharma, Glaukos, Sight Sciences, Ora, and Topcon for supporting this project. Very special thanks as well to our three Symposium co-chairs: Murray Fingeret, OD, Louis R. Pasquale, MD, FARVO, and Robert N. Weinreb, MD.

The excellent talks were informative and fascinating – you can access a new presentation from the symposium every Tuesday on YouTube The Glaucoma Foundation – YouTube or via our website. We will be spotlighting some of the talks in our newsletters, beginning in this issue with Dr. Janey Wiggs’ presentation on genetics and glaucoma.

Also on YouTube and the website is the interesting webinar held in May, at which Calvin W. Roberts, MD, a Program Manager at the new federal health agency, ARPA-H, discussed their new program that aims to bring together the expertise of vision scientists from multiple universities and laboratories to restore vision by transplanting a donor eye to those who are blind.

The next webinar in our ongoing series is scheduled for August 28, when Dr. Thomas Johnson will give an update on his optic nerve regeneration research.

We wish all our readers a very happy July 4th holiday and a good summer. We thank each of you for your ongoing support that makes our work possible.

With gratitude,

2f62325f 021a 3552 36a5 895873a129f5
Elena Sturman

July 2024 Newsletter